145 related articles for article (PubMed ID: 17000222)
1. Withdrawing implantable defibrillator shock therapy in terminally ill patients.
Lewis WR; Luebke DL; Johnson NJ; Harrington MD; Costantini O; Aulisio MP
Am J Med; 2006 Oct; 119(10):892-6. PubMed ID: 17000222
[TBL] [Abstract][Full Text] [Related]
2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
3. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillator in maintenance hemodialysis patients with ventricular tachyarrhythmias: a single-center experience.
Ito I; Kono K; Shinbo G; Tadokoro K; Abe C; Takemura N; Iemura T; Matsuhashi N; Nakano N; Ota S; Ishimitsu T; Matsuoka H
Hemodial Int; 2009 Jan; 13(1):48-54. PubMed ID: 19210278
[TBL] [Abstract][Full Text] [Related]
5. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
Spencker S; Coban N; Koch L; Schirdewan A; Müller D
Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
[TBL] [Abstract][Full Text] [Related]
6. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
[TBL] [Abstract][Full Text] [Related]
7. End-of-life decisions in ICD patients with malignant tumors.
Kobza R; Erne P
Pacing Clin Electrophysiol; 2007 Jul; 30(7):845-9. PubMed ID: 17584265
[TBL] [Abstract][Full Text] [Related]
8. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
[TBL] [Abstract][Full Text] [Related]
9. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
10. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
[TBL] [Abstract][Full Text] [Related]
11. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
12. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
[TBL] [Abstract][Full Text] [Related]
13. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
[TBL] [Abstract][Full Text] [Related]
14. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial.
Chevalier P; Cottraux J; Mollard E; Sai N; Brun S; Burri H; Restier L; Adeleine P
Am Heart J; 2006 Jan; 151(1):191. PubMed ID: 16368316
[TBL] [Abstract][Full Text] [Related]
15. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
16. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
[TBL] [Abstract][Full Text] [Related]
17. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?
Germano JJ; Reynolds M; Essebag V; Josephson ME
Am J Cardiol; 2006 Apr; 97(8):1255-61. PubMed ID: 16616037
[TBL] [Abstract][Full Text] [Related]
18. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Olshansky B; Wood F; Hellkamp AS; Poole JE; Anderson J; Johnson GW; Boineau R; Domanski MJ; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2007 Jun; 153(6):1089-94. PubMed ID: 17540216
[TBL] [Abstract][Full Text] [Related]
19. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
Mueller PS; Hook CC; Hayes DL
Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
[TBL] [Abstract][Full Text] [Related]
20. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
Marinskis G; van Erven L;
Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
